138 results on '"Sueta, Carla"'
Search Results
2. CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial
3. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study)
4. Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study
5. A Retrospective Cohort Evaluation of a Pharmacist-Led Approach for Transitioning Patients to an Angiotensin Receptor—Neprilysin Inhibitor.
6. Abstract P591: Prevalence and Prognosis Comparing the New vs. Old ACC/AHA/HFSA HF Stage Classification: The Atherosclerosis Risk in Communities (ARIC) Study
7. Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study)
8. Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy
9. Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study
10. Anger Proneness, Gender, and the Risk of Heart Failure
11. Polypharmacy in Heart Failure: Drugs to Use and Avoid
12. Contribution of medications and risk factors to QTc interval lengthening in the atherosclerosis risk in communities (ARIC) study
13. Are Trends in Hospitalization Prior to Hospice Use Associated With Hospice Episode Characteristics?
14. A Retrospective Cohort Evaluation of a Pharmacist-Led Approach for Transitioning Patients to an Angiotensin Receptor—Neprilysin Inhibitor
15. sj-pdf-1-jpp-10.1177_08971900221087087 - Supplemental material for A Retrospective Cohort Evaluation of a Pharmacist-Led Approach for Transitioning Patients to an Angiotensin Receptor—Neprilysin Inhibitor
16. sj-pdf-2-jpp-10.1177_08971900221087087 - Supplemental material for A Retrospective Cohort Evaluation of a Pharmacist-Led Approach for Transitioning Patients to an Angiotensin Receptor—Neprilysin Inhibitor
17. Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure)
18. Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study
19. Effects of Coping Skills Training on Quality of Life, Disease Biomarkers, and Clinical Outcomes in Patients With Heart Failure: A Randomized Clinical Trial
20. Effects of an Accelerated Intravenous Iron Regimen in Hospitalized Patients With Advanced Heart Failure and Iron Deficiency
21. Additional file 1 of A heart failure self-management program for patients of all literacy levels: A randomized, controlled trial [ISRCTN11535170]
22. Additional file 3 of A heart failure self-management program for patients of all literacy levels: A randomized, controlled trial [ISRCTN11535170]
23. Additional file 2 of A heart failure self-management program for patients of all literacy levels: A randomized, controlled trial [ISRCTN11535170]
24. 29 - Management of Chronic Heart Failure
25. In‐Hospital and Postdischarge Mortality Among Patients With Acute Decompensated Heart Failure Hospitalizations Ending on the Weekend Versus Weekday: The ARIC Study Community Surveillance
26. OPTIMAL MEDICAL THERAPY USE AND LONG-TERM OUTCOMES IN CABG-ELIGIBLE HEART FAILURE PATIENTS: INSIGHTS FROM THE STICH TRIAL
27. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure
28. OUTCOMES OF WEEKEND VERSUS WEEKDAY ADMISSION FOR ACUTE DECOMPENSATED HEART FAILURE IN PATIENTS WITH REDUCED EJECTION FRACTION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES SURVEILLANCE STUDY
29. Predictors of Medication Adherence in the Elderly: The Role of Mental Health
30. READMISSIONS FOR PATIENTS DISCHARGED WITH ACUTE DECOMPENSATED HEART FAILURE AND REDUCED VERSUS PRESERVED EJECTION FRACTION: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
31. Antihypertensive adherence and outcomes among community‐dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study
32. Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study
33. Medication Adherence Based on Part D Claims for Heart Failure Patients after Hospitalization (From the Atherosclerosis Risk in Communities Study)
34. Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy.
35. Predictors of Medication Adherence in the Elderly: The Role of Mental Health.
36. Contributors
37. Influence of Neurohormonal Antagonists on the Association of Loop Diuretic Dose with Mortality in Patients with Heart Failure: Insights From the UNITE-HF Registry
38. Reactive hyperemia is associated with adverse clinical outcomes in heart failure
39. Are Trends in Hospitalization Prior to Hospice Use Associated With Hospice Episode Characteristics?
40. MORTALITY FOLLOWING INITIATION OR DISCONTINUATION OF GUIDELINE DIRECTED MEDICAL THERAPIES IN HOSPITALIZED HEART FAILURE PATIENTS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
41. VALIDATION OF THE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) POOLED COHORT RISK EQUATIONS BY EDUCATION LEVEL: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
42. PROGNOSTIC IMPORTANCE OF SELF-REPORTED DYSPNEA FOR CARDIOVASCULAR OUTCOMES IN PERSONS WITHOUT PREVALENT CARDIOVASCULAR OR PULMONARY DISEASE: THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
43. Abstract 153: Estimating Medication Adherence Effects Using Part D Copayment as an Instrumental Variable in Heart Failure Patients
44. Abstract 19035: Cardiovascular QTc Interval-Prolonging Medications and the Risk of Death, Stroke and Incident Atrial Fibrillation in the Atherosclerosis Risk in Communities (ARIC) Study
45. Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure).
46. Antihypertensive adherence and outcomes among community‐dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study.
47. Abstract 118: Discharge Medications, Hospice Use and 30 Day Outcomes for Hospitalized Heart Failure Patients
48. Effects of an Accelerated Intravenous Iron Regimen in Hospitalized Patients With Advanced Heart Failure and Iron Deficiency
49. Abstract 13786: Contribution of Medications and Risk Factors to QT Interval Lengthening in the Atherosclerosis Risk in Communities (ARIC) Study
50. Stage A: Can Heart Failure Be Prevented?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.